University–Industry collaboration in the biopharmaceuticals: the Italian case

Journal of Technology Transfer

Volumn 41, Issue 4, 2016, Pages 818-840

  Giunta, Anna ^a   Pericoli, Filippo M ^b   Pierucci, Eleonora ^c  

^a ROMA TRE UNIVERSITY   (Italy)

^b Ministero dell'Economia e delle Finanze   (Italy)

^c UNIVERSITY OF BASILICATA   (Italy)

Author keywords

Biopharmaceutical industry; Co publishing; University Industry collaborations

Indexed keywords

MERGERS AND ACQUISITIONS; SOCIETIES AND INSTITUTIONS;

ACADEMIC RESEARCH; BIOPHARMACEUTICAL FIRMS; BIOPHARMACEUTICAL INDUSTRY; BIOPHARMACEUTICALS; EFFECTIVE INTERACTIONS; GEOGRAPHICAL PROXIMITY; INDUSTRY COLLABORATION; PROBABILISTIC MODELS;

EDUCATION;

EID: 84925397214     PISSN: 08929912     EISSN: 15737047     Source Type: Journal    
DOI: 10.1007/s10961-015-9402-2     Document Type: Article

References (84)

1. Abramo, G., D’Angelo, C., & Di Costa, F. (2011). University-industry research collaboration: A model to assess university capability. Higher Education, 62(2), 163–181.
2. Abramo, G., D’Angelo, C. A., Costa, F. D., & Solazzi, M. (2009). University-industry collaboration in Italy: A bibliometric examination. Technovation, 29(67), 498–507.
3. Abramo, G., D’Angelo, C. A., & Solazzi, M. (2010). Assessing public-private research collaboration: Is it possible to compare university performance? Scientometrics, 84(1), 173–197.
4. Abramovsky, L., Harrison, R., & Simpson, H. (2007). University research and the location of business R&D. The Economic Journal, 117(519), 114–141.
5. Abramovsky, L., Simpson, H. (2009). Geographic proximity and firm-university innovation linkages: Evidence from Great Britain. IFS Working Papers 0903, Institute for Fiscal Studies.
6. Achilladelis, B., & Antonakis, N. (2001). The dynamics of technological innovation: The case of the pharmaceutical industry. Research Policy, 30(4), 535–588.
7. Acs, Z. J., & Audretsch, D. B. (1990). Innovation and small firms. Cambridge: MIT Press.
8. Audia, P. G., Freeman, J. H., & Reynolds, P. D. (2006). Organizational foundings in community context: Instruments manufacturers and their interrelationship with other organizations. Administrative Science Quarterly, 51(3), 381–419.
9. Azagra-Caro, J. M. (2007). What type of faculty member interacts with what type of firm? Some reasons for the delocalisation of university-industry interaction. Technovation, 27(11), 704–715.
10. Azagra-Caro, J. M., Archontakis, F., Gutirrez-Gracia, A., & de Lucio, I. F. (2006). Faculty support for the objectives of university–industry relations versus degree of R&D cooperation: The importance of regional absorptive capacity. Research Policy, 35(1), 37–55.
11. Balconi, M., & Laboranti, A. (2006). University–industry interactions in applied research: The case of microelectronics. Research Policy, 35(10), 1616–1630.
12. Barbolla, A. M. B., & Corredera, J. R. C. (2009). Critical factors for success in university–industry research projects. Technology Analysis and Strategic Management, 21(5), 599–616.
13. Battelle. (2013). The economic impact of the US biopharmaceutical industry. Report for PhRMA, Battelle Technology Partnership Practice.
14. Bekkers, R., & Freitas, I. M. B. (2008). Analysing knowledge transfer channels between universities and industry: To what degree do sectors also matter? Research Policy, 37(10), 1837–1853. (Special Section Knowledge Dynamics out of Balance: Knowledge Biased, Skewed and Unmatched).
15. Boardman, P. C. (2008). Beyond the stars: The impact of affiliation with university biotechnology centers on the industrial involvement of university scientists. Technovation, 28(5), 291–297.
16. Boardman, P. C. (2009). Government centrality to university–industry interactions: University research centers and the industry involvement of academic researchers. Research Policy, 38(10), 1505–1516.
17. Boardman, P. C., & Corley, E. A. (2008). University research centers and the composition of research collaborations. Research Policy, 37(5), 900–913.
18. Boardman, P. C., & Ponomariov, B. L. (2009). University researchers working with private companies. Technovation, 29(2), 142–153.
19. Boschma, R. (2005). Proximity and innovation: A critical assessment. Regional Studies, 39(1), 61–74.
20. Bozeman, B., & Gaughan, M. (2007). Impacts of grants and contracts on academic researchers’ interactions with industry. Research Policy, 36(5), 694–707.
21. Brambor, T., Clark, W. R., & Golder, M. (2006). Understanding interaction models: Improving empirical analyses. Political Analysis, 14(1), 63–82.
22. Breschi, S., & Lissoni, F. (2001). Knowledge spillovers and local innovation systems: A critical survey. Industrial and Corporate Change, 10(4), 975–1005.
23. Brusoni, S., Criscuolo, P., & Geuna, A. (2005). The knowledge bases of the worlds largest pharmaceutical groups: What do patent citations to non-patent literature reveal? Economics of Innovation and New Technology, 14(5), 395–415.
24. Calvert, J., & Patel, P. (2003). University–industry research collaborations in the UK: Bibliometric trends. Science and Public Policy, 30(2), 85–96.
25. Cockburn, I., Henderson, R., Orsenigo, L., & Pisano, G. P. (1999). Pharmaceuticals and biotechnology. In D. C. Mowery (Ed.), US industry in 2000: Studies in competitive performance (pp. 77–90). Washington: The National Academies Press.
26. Cockburn, I. M., & Henderson, R. M. (1996). Public–private interaction in pharmaceutical research. Proceeding of the National Academy of Sciences of the United States of America, 93(23), 12725–12730.
27. Cockburn, I. M., & Henderson, R. M. (1998). Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery. Journal of Industrial Economics, 46(2), 157–182.
28. Cohen, W. M., & Levinthal, D. A. (1989). Innovation and learning: The two faces of R&D. Economic Journal, 99(397), 569–596.
29. Cohen, W. M., & Levinthal, D. A. (1990). Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly, 35(1), 128–152.
30. D’Este, P., Guy, F., & Iammarino, S. (2013). Shaping the formation of university–industry research collaborations: What type of proximity does really matter? Journal of Economic Geography, 13, 537–558.
31. D’Este, P., & Iammarino, S. (2010). The spatial profile of university–business research partnerships. Papers in Regional Science, 89(2), 335–350.
32. D’Este, P., & Patel, P. (2007). University-industry linkages in the UK: What are the factors underlying the variety of interactions with industry? Research Policy, 36(9), 1295–1313.
33. D’Este, P., & Perkmann, M. (2011). Why do academics engage with industry? The entrepreneurial university and individual motivations. The Journal of Technology Transfer, 36(3), 316–339.
34. EFPIA (2012). The pharmaceutical industry in figures: Key data 2012. http://www.efpia.eu/. last access 15 December 2014, European Federation of Pharmaceutical Industries and Associations.
35. EU-Commission. (2003). Third european report on science and technology indicators. Towards a knowledge-based economy. Technical report, Brussels: Directorate-General for Research.
36. EU-Commission. (2013). Communication from the commission to the european parliament, the council, the european economic and social committee and the committee of the regions. Official Journal of the European Union COM, 2013, 494. http://ec.europa.eu/transparency/regdoc/rep/1/2013/EN/1-2013-494-EN-F1-1.Pdf.
37. Fabrizio, K. R. (2009). Absorptive capacity and the search for innovation. Research Policy, 38(2), 255–267.
38. Farmindustria, (2014). Indicatori farmaceutici. Farmindustria: Rapporto. http://www.farmindustria.it/index.php?option=com_jdownloads&Itemid=0&view=finish&cid=98424&catid=42
39. Furman, J. L., Kyle, M. K., Cockburn, I. M., & Henderson, R. (2006). Public and private spillovers, location and the productivity of pharmaceutical research. Working Paper 12509, National Bureau of Economic Research.
40. Gambardella, A. (1992). Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980s. Research Policy, 21(5), 391–407.
41. Gambardella, A. (1995). Science and innovation: The US pharmaceutical industry during the 1980s. Cambridge: Cambridge University Press.
42. Gambardella, A., Orsenigo, L., & Pammolli, F. (2000). Global competitiveness in pharmaceuticals: A european perspective MPRA Paper 15965. Germany: University Library of Munich.
43. Gertler, M. S. (2003). Tacit knowledge and the economic geography of context, or the undefinable tacitness of being (there). Journal of Economic Geography, 3(1), 75–99.
44. Gittelman, M., & Kogut, B. (2003). Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns. Management Science, 49(4), 366–382.
45. Giuliani, E., Morrison, A., Pietrobelli, C., & Rabellotti, R. (2010). Who are the researchers that are collaborating with industry? An analysis of the wine sectors in Chile South Africa and Italy. Research Policy, 39(6), 748–761.
46. Giunta, A., Nifo, A., & Scalera, D. (2012). Subcontracting in italian industry: Labour division, firm growth and the North-South divide. Regional Studies, 46(8), 1067–1083.
47. Grabowski, H. (1995). Patents and new product development in the pharmaceutical and biotechnology industries. In A. Towse (Ed.), Symposium on industrial policy and the pharmaceutical industry (pp. 77–90). London: Office of Health Economics.
48. Grabowski, H. (2006). Patents and new product development in the pharmaceutical and biotechnology industries. In C. G. Smith & J. T. O’Donnell (Eds.), The Process of new drug discovery and development (pp. 533–546). London: Informa Healthcare USA Inc.
49. Grabowski, H. G., & Vernon, J. M. (1994). Returns to R&D on new drug introductions in the 1980s. Journal of Health Economics, 13(4), 383–406.
50. Grimpe, C., & Fier, H. (2010). Informal university technology transfer: A comparison between the United States and Germany. The Journal of Technology Transfer, 35(6), 637–650.
51. Haeussler, C., & Colyvas, J. A. (2011). Breaking the ivory tower: Academic entrepreneurship in the life sciences in UK and Germany. Research Policy, 40(1), 41–54. (Special Section on Heterogeneity and University–Industry Relations).
52. Henderson, R., & Cockburn, I. (1994). Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal, 15(S1), 63–84.
53. Henderson, R., Orsenigo, L., & Pisano, G. (1999). The pharmaceutical industry and the revolution in molecular biology: Exploring the interactions between scientific, institutional and organizational change. In D. Mowery & R. Nelson (Eds.), The sources of industrial advantages (pp. 267–310). Cambridge: Cambridge University Press.
54. Hewitt-Dundas, N. (2013). The role of proximity in university–business cooperation for innovation. The Journal of Technology Transfer, 38(2), 93–115.
55. Hicks, D. (1995). Published papers, tacit competencies and corporate management of the public/private character of knowledge. Industrial and Corporate Change, 4(2), 401–424.
56. Hicks, D. M., Isard, P. A., & Martin, B. R. (1996). A morphology of Japanese and European corporate research networks. Research Policy, 25(3), 359–378.
57. Howells, J. R. L. (2002). Tacit knowledge, innovation and economic geography. Urban Studies, 39(5–6), 871–884.
58. Iacobucci, D., & Micozzi, A. (2014). How to evaluate the impact of academic spin-offs on local development: An empirical analysis of the italian case. The Journal of Technology Transfer. doi:10.1007/s10961-014-9357-8.
59. Jaffe, A. B. (1989). Real effects of academic research. American Economic Review, 79(5), 957–970.
60. Koenig, M. E. (1983). A bibliometric analysis of pharmaceutical research. Research Policy, 12(1), 15–36.
61. Laursen, K., Reichstein, T., & Salter, A. (2011). Exploring the effect of geographical proximity and university quality on university–industry collaboration in the United Kingdom. Regional Studies, 45(4), 507–523.
62. Leten, B., Kelchtermans, S., Belderbos, R. (2010). Internal basic research, external basic research and the technological performance of pharmaceutical firms. Working Papers 2010/12, Hogeschool-Universiteit Brussel, Faculteit Economie en Management.
63. Link, A., & Rees, J. (1990). Firm size, university based research, and the returns to R&D. Small Business Economics, 2(1), 25–31.
64. Link, A. N., Siegel, D. S., & Bozeman, B. (2007). An empirical analysis of the propensity of academics to engage in informal university technology transfer. Industrial and Corporate Change, 16(4), 641–655.
65. Mansfield, E., & Lee, J.-Y. (1996). The modern university: Contributor to industrial innovation and recipient of industrial R&D support. Research Policy, 25(7), 1047–1058.
66. Mueller, P. (2006). Exploring the knowledge filter: How entrepreneurship and universityindustry relationships drive economic growth. Research Policy, 35(10), 1499–1508.
67. Muscio, A., & Pozzali, A. (2013). The effects of cognitive distance in university–industry collaborations: Some evidence from italian universities. The Journal of Technology Transfer, 38(4), 486–508.
68. Narin, F., & Rozek, R. P. (1988). Bibliometric analysis of US pharmaceutical industry research performance. Research Policy, 17(3), 139–154.
69. Orsenigo, L. (2001). The (failed) development of a biotechnology cluster: The case of Lombardy. Small Business Economics, 17(1–2), 77–92.
70. Owen-Smith, J., & Powell, W. W. (2004). Knowledge networks as channels and conduits: The effects of spillovers in the Boston biotechnology community. Organization Science, 15(1), 5–21.
71. Pammolli, F., & Salerno, N. C. (2011). Retail distribution of pharmaceuticals: Italy at the crossroads. Economia e Politica Industriale, 2, 125148.
72. Pavitt, K. (1984). Sectoral patterns of technical change: Towards a taxonomy and a theory. Research Policy, 13(6), 343–373.
73. Perkmann, M., Tartari, V., McKelvey, M., Autio, E., Brostrm, A., & DEste, P. (2013). Academic engagement and commercialisation: A review of the literature on University–Industry relations. Research Policy, 42(2), 423–442.
74. Ponds, R., Van Oort, F., & Frenken, K. (2007). The geographical and institutional proximity of research collaboration. Papers in Regional Science, 86(3), 423–443.
75. Ponomariov, B. L. (2008). Effects of university characteristics on scientists’ interactions with the private sector: An exploratory assessment. The Journal of Technology Transfer, 33(5), 485–503.
76. Rosenberg, N. (1990). Why do firms do basic research (with their own money)? Research Policy, 19(2), 165–174.
77. Rubenstein, A. (1989). Managing technology in the decentralized firm. New York: Wiley series in engineering and technology management, Wiley.
78. Ryan, M. P. (1998). Diplomacy, global competition and the politics of intellectual property. Washington, DC: Brookings Institution Press.
79. Slavtchev, V. (2013). Proximity and the transfer of academic knowledge: Evidence from the spatial pattern of industry collaborations of east german professors. Regional Studies, 47(5), 686–702.
80. Sternitzke, C. (2010). Knowledge sources, patent protection, and commercialization of pharmaceutical innovations. Research Policy, 39(6), 810–821.
81. Stuart, T. E., Ozdemir, S. Z., & Ding, W. W. (2007). Vertical alliance networks: The case of University-Biotechnology-Pharmaceutical alliance chains. Research Policy, 36(4), 477–498.
82. Ward, M. R., & Dranove, D. (1995). The vertical chain of research and development in the pharmaceutical industry. Economic Inquiry, 33(1), 70–87.
83. Zucker, L., & Darby, M. (2001). Capturing technological opportunity via Japan’s star scientists: Evidence from japanese firms’ biotech patents and products. The Journal of Technology Transfer, 26(1–2), 37–58.
84. Zucker, L. G., & Darby, M. R. (1997). Present at the biotechnological revolution: Transformation of technological identity for a large incumbent pharmaceutical firm. Research Policy, 26(4–5), 429–446.